TrimTabs ETF Trust - Donoghue Forlines Tactical High Yield ETF

ABHY tracks an index that invests in US-listed high yield ETFs while applying a downside protection. The risk-managed fund employs a tactical strategy that toggles between high yield and US Treasury ETFs. This tactical switch is determined by a daily buy-sell signal. Full exposure is allocated to high yield ETFs when a buy signal is triggered, while 80% is allocated to US Treasurys when it triggers otherwise. Underlying ETFs must meet certain expense ratio and AUM requirements to be considered. In addition, both must have an investment process that excludes factors, hedges and long/short strategies. The underlying ETFs are weighted based on their respective expenses and AUM, whether its junk bonds or Treasurys. The index is rebalanced quarterly and reconstituted annually. DFHYs investors should anticipate frequent trading. Prior to Nov. 29, 2021, the fund was named TrimTabs Donoghue Forlines Tactical High Yield and tracked the TrimTabs Donoghue Forlines Tactical High Yield Index. Prior to Nov. 13, 2024 the fund name was Donoghue Forlines Tactical High Yield ETF and traded under the ticker DFHY.

TrimTabs ETF Trust - Donoghue Forlines Tactical High Yield ETF trades as ABHY on CBOE. The company is classified in Financial Services / Asset Management and reports in USD.

The current profile places the business in Asset Management. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Peer data is not available for this symbol yet.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $0, beta of 0.32, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

ABHY currently shows total debt of N/A and beta of 0.32. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website is not available.

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.